145 related articles for article (PubMed ID: 27122943)
1. Author Reply to Letter to the Editor: Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry.
Lai CC; Mar GY
Acta Cardiol Sin; 2016 Jan; 32(1):121-2. PubMed ID: 27122943
[No Abstract] [Full Text] [Related]
2. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
[TBL] [Abstract][Full Text] [Related]
3. Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry.
Lai CC; Yip HK; Lin TH; Wu CJ; Lai WT; Liu CP; Chang SC; Mar GY
Acta Cardiol Sin; 2014 Nov; 30(6):553-64. PubMed ID: 27122834
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of patients receiving drug-eluting stents.
Philpott AC; Southern DA; Clement FM; Galbraith PD; Traboulsi M; Knudtson ML; Ghali WA;
CMAJ; 2009 Jan; 180(2):167-74. PubMed ID: 19095719
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a nonrandomized comparison.
Munir M; Aliota J; Ahmed A; Mohammed A; Lee VV; Elayda MA; Wilson JM
Tex Heart Inst J; 2011; 38(5):508-15. PubMed ID: 22163124
[TBL] [Abstract][Full Text] [Related]
8. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
[TBL] [Abstract][Full Text] [Related]
9. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
Thuesen L; Kelbaek H; Kløvgaard L; Helqvist S; Jørgensen E; Aljabbari S; Krusell LR; Jensen GV; Bøtker HE; Saunamäki K; Lassen JF; van Weert A;
Am Heart J; 2006 Dec; 152(6):1140-5. PubMed ID: 17161067
[TBL] [Abstract][Full Text] [Related]
11. Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: the EURHOBOP study.
Barros V; Pereira M; Araújo C; Braga P; Azevedo A
Rev Port Cardiol; 2015; 34(7-8):449-56. PubMed ID: 26162287
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
13. A comparison of bare-metal and drug-eluting stents for off-label indications.
Marroquin OC; Selzer F; Mulukutla SR; Williams DO; Vlachos HA; Wilensky RL; Tanguay JF; Holper EM; Abbott JD; Lee JS; Smith C; Anderson WD; Kelsey SF; Kip KE
N Engl J Med; 2008 Jan; 358(4):342-52. PubMed ID: 18216354
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis comparing clinical effectiveness of drug-eluting stents, bare metal stents and coronary artery bypass surgery.
Oh EH; Imanaka Y; Hayashida K; Kobuse H
Int J Evid Based Healthc; 2007 Sep; 5(3):296-304. PubMed ID: 21631793
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
16. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
Malenka DJ; Kaplan AV; Lucas FL; Sharp SM; Skinner JS
JAMA; 2008 Jun; 299(24):2868-76. PubMed ID: 18577731
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting or bare-metal stents for acute myocardial infarction.
Mauri L; Silbaugh TS; Garg P; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Normand SL
N Engl J Med; 2008 Sep; 359(13):1330-42. PubMed ID: 18815397
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
